This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Propofol II (2013-11-25)
- Starting date:
- November 25, 2013
- Posting date:
- December 9, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-37037
Recalled Products
Propofol II
Reason
A visible particule was observed during the inspection of retained samples from the injectable emulsion Propofol-II (batch 29609DJ).
Depth of distribution
Wholesalers, hospitals and pharmacies.
Affected products
Propofol II
DIN, NPN, DIN-HIM
DIN 02376865
Dosage form
Emulsion
Strength
10 mg/mL
Lot or serial number
29609DJ
Companies
- Recalling Firm
-
Hospira Healthcare Corporation
1111 Dr. Frederik Philips Blvd.,
Saint-Laurent
H4M 2X6
Quebec
CANADA
- Marketing Authorization Holder
-
Hospira Healthcare Corporation
1111 Dr. Frederik Philips Blvd.,
Saint-Laurent
H4M 2X6
Quebec
CANADA